Novartis India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2026 ,inter alia, to consider and approve The Audited Financial Results ....
NOVARTIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Novartis India has informed BSE that its Board of Directors will meet on Tuesday, May 12, 2026, to consider and approve the Audited Financial Results for the quarter and financial year ended March 31, 2026. This is a routine regulatory disclosure under SEBI's Listing Obligations and Disclosure Requirements. Additionally, the company has announced that the trading window for designated persons and insiders will be closed from April 1, 2026, until 48 hours after the financial results are declared. No financial numbers or specific agenda items beyond the audited results have been disclosed in this filing.
This is a standard procedural filing with no direct impact on shareholders. Investors should watch for the actual audited results on May 12, 2026, which will provide clarity on the company's full-year FY26 performance.